Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 10, 2007, Pages 3912-3922

  Hahner, Stefanie ^a   Loeffler, Melanie ^a   Fassnacht, Martin ^a   Weismann, Dirk ^a   Koschker, Ann Cathrin ^a   Quinkler, Marcus ^b   Decker, Oliver ^c   Arlt, Wiebke ^d   Allolio, Bruno ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; FLUDROCORTISONE; HYDROCORTISONE; LEVOTHYROXINE; ORAL CONTRACEPTIVE AGENT; PRASTERONE; TESTOSTERONE;

ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; QUESTIONNAIRE; SELF EVALUATION; SELF HELP; SHORT FORM 36; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

EID: 35348987031     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-0685     Document Type: Article

References (43)

1. Arlt W, Allolio B 2003 Adrenal insufficiency. Lancet 361:1881-1893
2. Lovas K, Loge JH, Husebye ES 2002 Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56:581-588
3. Thomsen AF, Kvist TK, Andersen PK, Kessing LV 2006 The risk of affective disorders in patients with adrenocortical insufficiency. Psychoneuroendocrinology 31:614-622
4. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G 2006 Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849-4853
5. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
6. Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G 1997 Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. J Clin Endocrinol Metab 82:2578-2585
7. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B 1999 Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341:1013-1020
8. Miller KK, Sesmilo G, Schiller A, Schoenfeld D, Burton S, Klibanski A 2001 Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 86:561-567
9. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK 2000 Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85:4650-4656
10. Johannsson G, Burman P, Wiren L, Engstrom BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA 2002 Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87:2046-2052
11. Brooke AM, Kalingag LA, Miraki-Moud F, Camacho-Hubner C, Maher KT, Walker DM, Hinson JP, Monson JP 2006 Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement. J Clin Endocrinol Metab 91:3773-3779
12. Lovas K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebo BG, Myking OL, Kampe O, Husebye ES 2003 Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88:1112-1118
13. Libe R, Barbetta L, Dall'Asta C, Salvaggio F, Gala C, Beck-Peccoz P, Ambrosi B 2004 Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism. J Endocrinol Invest 27:736-741
14. van Thiel SW, Romijn JA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B, Smit JW 2005 Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial. J Clin Endocrinol Metab 90:3295-3303
15. Ware Jr JE, Sherbourne CD 1992 The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473-483
16. Nemeth G 2006 Health related quality of life outcome instruments. Eur Spine J 15(Suppl 1):S44-S51
17. Garratt A, Schmidt L, Mackintosh A, Fitzpatrick R 2002 Quality of life measurement: bibliographic study of patient assessed health outcome measures. BMJ 324:1417
18. Brahler E, Schumacher J, Brahler C 2000 [First all-Germany standardization of the brief form of the Gissen Complaints Questionnaire GBB-24]. Psychother Psychosom Med Psychol 50:14-21
19. Zigmond AS, Snaith RP 1983 The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370
20. Ellert U, Bellach BM 1999 [The SF-36 in the Federal Health Survey-description of a current normal sample]. Gesundheitswesen 61 Spec No:S184-S190.
21. Hinz A, Brahler E, Schwarz R, Schumacher J, Stirn A 2005 [How useful is the calculation of total scores for questionnaires concerning health related quality of life?]. Psychother Psychosom Med Psychol 55:221-228
22. Deutsche Rentenversicherung Bund GP-uÖ, Kommunikation 2006 Statistik der Deutschen Rentenversicherung-"Rentenbestand". www.vdr.de
23. Bundesministerium für Gesundheit und Soziale Sicherung Deutschland (Official web site of the German Ministry of Health, www.bmg.bund.de) 2005
24. Gunzelmann T, Albani C, Beutel M, Brahler E 2006 [Subjective health of older people in view of the SF-36: values from a large community-based sample]. Z Gerontol Geriatr 39:109-119
25. Kvien TK, Kaasa S, Smedstad LM 1998 Performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures. J Clin Epidemiol 51:1077-1086
26. Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T 2007 A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res 16:179-189
27. Kravitz RL, Greenfield S, Rogers W, Manning Jr WG, Zubkoff M, Nelson EC, Tarlov AR, Ware Jr JE 1992 Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study. JAMA 267:1617-1623.
28. McHorney CA, Ware Jr JE, Raczek AE 1993 The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247-263
29. Morsch CM, Goncalves LF, Barros E 2006 Health-related quality of life among haemodialysis patients - relationship with clinical indicators, morbidity and mortality. J Clin Nurs 15:498-504
30. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK 2006 Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 91:447-453
31. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, Smit JW, Roelfsema F, Lamberts SW, Romijn JA 2005 Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 90:3279-3286
32. Kauppinen-Makelin R, Sane T, Sintonen H, Markkanen H, Valimaki MJ, Loyttyniemi E, Niskanen L, Reunanen A, Stenman UH 2006 Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab 91:3891-3896
33. Dekkers OM, Biermasz NR, Smit JW, Groot LE, Roelfsema F, Romijn JA, Pereira AM 2006 Quality of life in treated adult craniopharyngioma patients. Eur J Endocrinol 154:483-489
34. Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W, Allolio B 2002 Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215-222
35. Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, Cooper DS, Schuff KG, Braverman LE, Skarulis MC, Davies TF, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Weintraub BD, Ridgway EC, Ladenson PW 2006 A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab 91:878-884
36. Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP 1997 Glucocorticoid replacement therapy: are patients over treated and does it matter? Clin Endocrinol (Oxf) 46:255-261
37. Howlett TA 1997 An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 46:263-268
38. Riedel M, Wiese A, Schurmeyer TH, Brabant G 1993 Quality of life in patients with Addison's disease: effects of different cortisol replacement modes. Exp Clin Endocrinol 101:106-111
39. Arlt W, Rosenthal C, Hahner S, Allolio B 2006 Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 64:384-389
40. Ross RJ, Optimization of adrenal glucocorticoid replacement. Program of the 88th Annual Meeting of the American Endocrine Society, Boston, MA, 2006, p S43-2
41. Vissers KC, De Jongh RF, Crul BJ, Vinken P, Meert TF 2004 Adrenalectomy affects pain behavior of rats after formalin injection. Life Sci 74:1243-1251
42. Bogdanov AI, Yarushkina NI 2003 Mechanisms of the effects of adrenocorticotropic hormone on pain sensitivity in rats. Neurosci Behav Physiol 33:795-798
43. Lariviere WR, Melzack R 2000 The role of corticotropin-releasing factor in pain and analgesia. Pain 84:1-12